Oxford Nanopore Technologies plc Stock
Equities
ONT
GB00BP6S8Z30
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.3 GBX | +2.00% | -2.72% | -48.46% |
Sales 2024 * | 188M 240M | Sales 2025 * | 242M 308M | Capitalization | 926M 1.18B |
---|---|---|---|---|---|
Net income 2024 * | -150M -191M | Net income 2025 * | -133M -169M | EV / Sales 2024 * | 3.26 x |
Net cash position 2024 * | 311M 396M | Net cash position 2025 * | 197M 251M | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
-6.28
x | P/E ratio 2025 * |
-7.24
x | Employees | 1,238 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.12% |
Latest transcript on Oxford Nanopore Technologies plc
1 day | +2.00% | ||
1 week | -2.72% | ||
1 month | +6.03% | ||
3 months | -17.46% | ||
6 months | -44.32% | ||
Current year | -48.46% |
Managers | Title | Age | Since |
---|---|---|---|
James WIllcocks
FOU | Founder | - | 04-12-31 |
Gordon Sanghera
FOU | Founder | - | 04-12-31 |
Nicholas Keher
DFI | Director of Finance/CFO | 42 | Jan. 21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adrian Hennah
BRD | Director/Board Member | 66 | 21-06-23 |
Director/Board Member | 58 | Dec. 18 | |
Chairman | 59 | 22-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.13% | 5 M€ | +15.85% | ||
0.09% | 7 M€ | -.--% | - | |
0.03% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 107.3 | +2.00% | 1,864,299 |
24-05-30 | 105.2 | +0.10% | 638,375 |
24-05-29 | 105.1 | -4.28% | 1,160,253 |
24-05-28 | 109.8 | -0.45% | 1,155,258 |
24-05-24 | 110.3 | -0.72% | 1,649,854 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.46% | 1.18B | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- ONT Stock